Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 166

The DOI matches its Crossref record.

Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy

Open access
Rutkowski, Stefan, Gerber, Nicolas Ulrich, von Hoff, Katja, Gnekow, Astrid, Bode, Udo, Graf, Norbert, Berthold, Frank, Henze, Günter, Wolff, Johannes E.A., Warmuth-Metz, Monika, Soerensen, Niels, Emser, Angela, Ottensmeier, Holger, Deinlein, Frank, Schlegel, Paul-Gerhardt, Kortmann, Rolf-Dieter, Pietsch, Torsten, Kuehl, Joachim · 2009 · Neuro-Oncology

Abstract

To investigate the utility of postoperative chemotherapy in delaying radiotherapy and to identify prognostic factors in early childhood medulloblastoma, we studied children younger than 3 years of age registered to the HIT-SKK'87 (Therapieprotokoll für Säuglinge und Kleinkinder mit Hirntumoren [Brain Tumor Radiotherapy for Infants and Toddlers with Medulloblastoma] 1987) trial who received systemic interval chemotherapy until craniospinal radiotherapy was applied at 3 years of age or at relapse, from 1987 to 1993. Children with postoperative residual tumor or metastatic disease received systemic induction chemotherapy prior to interval chemotherapy. Twenty-nine children were eligible for analyses (median age, 1.7 years; median follow-up, 12.6 years). In children without macroscopic metastases, rates (+/-SEM) for 10-year progression-free survival (PFS) and overall survival (OS) were 52.9% +/- 12.1% and 58.8% +/- 11.9% (complete resection), and 55.6% +/- 16.6% and 66.7% +/- 15.7% (incomplete resection), compared with 0% and 0% in children with macroscopic metastases. Survival was superior in nine children with desmoplastic or extensive nodular histology compared with 20 children with classic medulloblastoma (10-year PFS, 88.9% +/- 10.5% and 30.0% +/- 10.3%, p = 0.003; OS, 88.9% +/- 10.5% and 40.0% +/- 11.0%, p = 0.006). Eleven of 12 children with tumor progression during chemotherapy had classic medulloblastoma. After treatment, IQ scores were inferior compared with nonirradiated children from the subsequent study, HIT-SKK'92. Classic histology, metastatic disease, and male gender were independent adverse risk factors for PFS and OS in 72 children from HIT-SKK'87 and HIT-SKK'92 combined. In terms of survival, craniospinal radiotherapy was successfully delayed especially in young children with medulloblastoma of desmoplastic/extensive nodular histology, which was a strong independent favorable prognostic factor. Because of the neurocognitive deficits of survivors, the emerging concepts to avoid craniospinal radiotherapy should rely on the histological medulloblastoma subtype.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1215/15228517-2008-084

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 166

Metadata

Authors
Rutkowski, S., Gerber, N. U., von Hoff, K., Gnekow, A., Bode, U., Graf, N., Berthold, F., Henze, G., Wolff, J. E. A., Warmuth-Metz, M., Soerensen, N., Emser, A., Ottensmeier, H., Deinlein, F., Schlegel, P.-G., Kortmann, R.-D., Pietsch, T., & Kuehl, J.
Venue
Neuro-Oncology
Published
2009-04-01
Volume
11
Issue
2
Pages
201-210
ISSN
  • 1522-8517 (ISSN-L)
  • 1523-5866
OpenAlex
W2123599358
Cited by
166
References
0
FWCI
5.35
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. https://app.cochat.ai/papers/10.1215/15228517-2008-084
The paper
Rutkowski, S., Gerber, N. U., von Hoff, K., Gnekow, A., Bode, U., Graf, N., Berthold, F., Henze, G., Wolff, J. E. A., Warmuth-Metz, M., Soerensen, N., Emser, A., Ottensmeier, H., Deinlein, F., Schlegel, P.-G., Kortmann, R.-D., Pietsch, T., & Kuehl, J. (2009). Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro-Oncology. https://doi.org/10.1215/15228517-2008-084

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.